Lympho Bob

The makers of the bispecific Epcoritamab just issued a press releasewith some interim results from the phase 3 clinical trial for Epcoritama...

As you know, I'm a big fan of  two things when it comes to Follicular Lymphoma -- getting as much good information as possible, and pati...

If you're on Facebook, you might have experienced its "memories" feature. Sometimes it will send you a notification letting yo...

As I have mentioned before, late May and early June is typically a busy time for Follicular Lymphoma research, with presentations at ASCO. (...

The Follicular Lymphoma Foundation held a webinar a couple of weeks ago called " Charting our Progress Towards a Cure ." It's ...

I like to highlight webinars or other educational events that I think will be useful to us, and the Lymphoma Research Foundation has a coupl...

CURE magazine has a nice interview with Dr. Christina Poh of the Fred Hutch Cancer Center about Tafasitamab.  As you might remember, Tafasi...